FDA Inspection 1215867 — NewYork-Presbyterian/Weill Cornell Medical Center
The FDA completed an inspection of NewYork-Presbyterian/Weill Cornell Medical Center on August 21, 2023 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 21, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)